Samsung’s venture investment unit is looking to invest in California-based medical device startup, Exo, in a round that could climb to $100 million, Bloomberg reported, citing anonymous sources.
The round is being led by Sands Capital, Bold Capital and Qubit Health Capital, the report said, adding that Qubit’s chairman, Imar Ishrak, would join Exo’s board.
Founded in 2015, Exo makes handheld medical imaging devices that use a combination of artificial intelligence, medical imaging and silicon technology for ultrasound examinations like scanning lungs or echocardiograms. The device plugs into a smartphone, and medical examiners can scan patients, document, and share exam reports using one app.
The company has so far raised more than $320 million in funding from investors including RA Capital Management, BlackRock, Sands Capital, Intel, Sony, and Avidity Partners. The company most recently raised a $220 million in Series C round in 2021.
Exo is also in talks to partner with Samsung Medison Co., which makes medical devices for ultrasound diagnostics and digital X-ray systems, the report said.
Exo, Samsung, Sands Capital, Bold Capital and Qubit Health did not immediately return requests for comment.
Samsung’s venture investment unit is looking to invest in California-based medical device startup, Exo, in a round that could climb to $100 million, Bloomberg reported, citing anonymous sources.
The round is being led by Sands Capital, Bold Capital and Qubit Health Capital, the report said, adding that Qubit’s chairman, Imar Ishrak, would join Exo’s board.
Founded in 2015, Exo makes handheld medical imaging devices that use a combination of artificial intelligence, medical imaging and silicon technology for ultrasound examinations like scanning lungs or echocardiograms. The device plugs into a smartphone, and medical examiners can scan patients, document, and share exam reports using one app.
The company has so far raised more than $320 million in funding from investors including RA Capital Management, BlackRock, Sands Capital, Intel, Sony, and Avidity Partners. The company most recently raised a $220 million in Series C round in 2021.
Exo is also in talks to partner with Samsung Medison Co., which makes medical devices for ultrasound diagnostics and digital X-ray systems, the report said.
Exo, Samsung, Sands Capital, Bold Capital and Qubit Health did not immediately return requests for comment.
It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout. The point of using Lorem Ipsum is that it has a more-or-less normal distribution of letters, as opposed to using ‘Content here, content here’, making it look like readable English. Many desktop publishing packages and web page editors now use Lorem Ipsum as their default model text, and a search for ‘lorem ipsum’ will uncover many web sites still in their infancy.
It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout. The point of using Lorem Ipsum is that it has a more-or-less normal distribution of letters, as opposed to using ‘Content here, content here’, making it look like readable English. Many desktop publishing packages and web page editors now use Lorem Ipsum as their default model text, and a search for ‘lorem ipsum’ will uncover many web sites still in their infancy.
The point of using Lorem Ipsum is that it has a more-or-less normal distribution of letters, as opposed to using ‘Content here, content here’, making
The point of using Lorem Ipsum is that it has a more-or-less normal distribution of letters, as opposed to using ‘Content here, content here’, making it look like readable English. Many desktop publishing packages and web page editors now use Lorem Ipsum as their default model text, and a search for ‘lorem ipsum’ will uncover many web sites still in their infancy.
It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout. The point of using Lorem Ipsum is that it has a more-or-less normal distribution
Copyright BlazeThemes. 2023
